150 related articles for article (PubMed ID: 35738628)
1. The Platelet-to-Lymphocyte Ratio Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative Treatment.
Aoyama T; Ju M; Komori K; Tamagawa H; Tamagawa A; Onodera A; Morita J; Hashimoto I; Ishiguro T; Endo K; Cho H; Onuma S; Fukuda M; Oshima T; Yukawa N; Rino Y
In Vivo; 2022; 36(4):1916-1922. PubMed ID: 35738628
[TBL] [Abstract][Full Text] [Related]
2. The Systemic Inflammation Score Is an Independent Prognostic Factor for Esophageal Cancer Patients who Receive Curative Treatment.
Aoyama T; Ju M; Komori K; Tamagawa H; Tamagawa A; Maezawa Y; Hashimoto I; Kano K; Hara K; Cho H; Segami K; Machida D; Nakazono M; Oshima T; Yukawa N; Rino Y
Anticancer Res; 2022 May; 42(5):2711-2717. PubMed ID: 35489731
[TBL] [Abstract][Full Text] [Related]
3. Clinical Impact of Platelet-to-albumin Ratio on Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T; Ju M; Komori K; Tamagawa H; Tamagawa A; Morita J; Hashimoto I; Ishiguro T; Onodera A; Cho H; Endo K; Onuma S; Kano K; Hara K; Fukuda M; Oshima T; Yukawa N; Rino Y
In Vivo; 2022; 36(4):1896-1902. PubMed ID: 35738593
[TBL] [Abstract][Full Text] [Related]
4. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis.
Yodying H; Matsuda A; Miyashita M; Matsumoto S; Sakurazawa N; Yamada M; Uchida E
Ann Surg Oncol; 2016 Feb; 23(2):646-54. PubMed ID: 26416715
[TBL] [Abstract][Full Text] [Related]
6. The Clinical Impact of the Pretreatment Platelet-to-Lymphocyte Ratio in Gastric Cancer Patients Who Receive Curative Treatment.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kazama K; Numata M; Kamiya N; Tamagawa H; Sawazaki S; Kawahara S; Komori K; Tamagawa A; Cho H; Morita J; Otani K; Kato A; Tanabe M; Oshima T; Yukawa N; Saito A; Rino Y
In Vivo; 2023; 37(6):2696-2703. PubMed ID: 37905661
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of preoperative platelets to lymphocytes ratio (PLR) on survival for oesophageal and junctional carcinoma treated with neoadjuvant chemotherapy: A retrospective monocentric study on 153 patients.
Messager M; Neofytou K; Chaudry MA; Allum WH
Eur J Surg Oncol; 2015 Oct; 41(10):1316-23. PubMed ID: 26166786
[TBL] [Abstract][Full Text] [Related]
8. Clinical Impact of Preoperative Albumin-Bilirubin Status in Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T; Ju M; Machida D; Komori K; Tamagawa H; Tamagawa A; Maezawa Y; Kano K; Hara K; Segami K; Hashimoto I; Nagasawa S; Nakazono M; Oshima T; Yukawa N; Rino Y
In Vivo; 2022; 36(3):1424-1431. PubMed ID: 35478112
[TBL] [Abstract][Full Text] [Related]
9. Preoperative platelet-lymphocyte ratio is an independent factor of poor prognosis after curative surgery for colon cancer.
Bailon-Cuadrado M; Choolani-Bhojwani E; Tejero-Pintor FJ; Sanchez-Gonzalez J; Rodriguez-Lopez M; Perez-Saborido B; Marcos-Rodriguez JL
Updates Surg; 2018 Mar; 70(1):33-39. PubMed ID: 29222632
[TBL] [Abstract][Full Text] [Related]
10. [Effect of preoperative monocyte-lymphocyte ratio on prognosis of patients with resectable esophagogastric junction cancer].
Zhou WJ; Wu J; Li XD; Wang Q; Ni XF; Jiang JT; Ji M; Wu CP
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):178-183. PubMed ID: 28316215
[No Abstract] [Full Text] [Related]
11. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.
Han LH; Jia YB; Song QX; Wang JB; Wang NN; Cheng YF
Asian Pac J Cancer Prev; 2015; 16(6):2245-50. PubMed ID: 25824745
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte to Monocyte Ratio Is an Independent Prognostic Factor in Patients With Esophageal Cancer Who Receive Curative Treatment.
Aoyama T; Kato A; Maezawa Y; Hashimoto I; Hara K; Komori K; Kawahara S; Numata M; Kazama K; Sawazaki S; Kamiya N; Yoshizawa S; Otani K; Tamagawa A; Cho H; Tamagawa H; Oshima T; Yukawa N; Saito A; Rino Y
Anticancer Res; 2024 Jan; 44(1):339-346. PubMed ID: 38159996
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma.
Jung J; Park SY; Park SJ; Park J
Tumour Biol; 2016 Jun; 37(6):7149-54. PubMed ID: 26662960
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer.
Xie X; Luo KJ; Hu Y; Wang JY; Chen J
Dis Esophagus; 2016 Jan; 29(1):79-85. PubMed ID: 25410116
[TBL] [Abstract][Full Text] [Related]
15. Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy.
Wang Y; Xu F; Pan J; Zhu Y; Shao X; Sha J; Wang Z; Cai Y; Liu Q; Dong B; Xue W; Huang Y
BMC Cancer; 2016 May; 16():329. PubMed ID: 27222030
[TBL] [Abstract][Full Text] [Related]
16. Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma.
Feng JF; Huang Y; Chen QX
World J Surg Oncol; 2014 Mar; 12():58. PubMed ID: 24641770
[TBL] [Abstract][Full Text] [Related]
17. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy.
Ji WH; Jiang YH; Ji YL; Li B; Mao WM
Dis Esophagus; 2016 Jul; 29(5):403-11. PubMed ID: 25625421
[TBL] [Abstract][Full Text] [Related]
18. CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for the Esophageal Cancer Patients Who Received Curative Treatment.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kazama K; Komori K; Numata M; Tamagawa A; Fukuda M; Cho H; Morita J; Yoshizawa S; Otani K; Kato A; Tanabe M; Nakazono M; Kawahara S; Oshima T; Saito A; Yukawa N; Rino Y
Anticancer Res; 2024 Feb; 44(2):815-822. PubMed ID: 38307573
[TBL] [Abstract][Full Text] [Related]
19. Effect of dynamic platelet-to-lymphocyte ratio on the prognosis of patients with esophageal squamous cell carcinoma receiving chemoradiotherapy.
He D; Du S; He S; Song H; Pu B; Zhang G; Yang C
Medicine (Baltimore); 2023 Dec; 102(49):e36554. PubMed ID: 38065887
[TBL] [Abstract][Full Text] [Related]
20. Platelet to lymphocyte ratio is a predictive marker of prognosis and therapeutic effect of postoperative chemotherapy in non-metastatic esophageal squamous cell carcinoma.
Yang Y; Xu H; Zhou L; Deng T; Ning T; Liu R; Zhang L; Wang X; Ge S; Li H; Ba Y
Clin Chim Acta; 2018 Apr; 479():160-165. PubMed ID: 29325800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
